Tivic health and feinstein institute present new data showing personalized vagus nerve stimulation method optimizes impact on autonomic nervous system

Fremont, calif.--(business wire)--tivic health® systems, inc. (nasdaq: tivc), a diversified therapeutics company, announced today new data that shows personalizing its non-invasive vagus nerve stimulation (ncvns) method optimized the stimulation's impact on autonomic nervous system activity. tivic health believes these findings strongly support its strategy to develop highly personalized neuromodulation devices that can better address inflammatory, cardiac and neurologic disorders compared to c.
TIVC Ratings Summary
TIVC Quant Ranking